未知股票 NOVA 深 沪
已收盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 0.00亿
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率 3.44%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreements
FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreements Changes dateline, updates paragraph 1, adds Regeneron's deal details May 4 (Reuters) - U.S. President Donald Trump secured agreements with 17 major pharmaceutical companies to bring U.S. prescription drug pric
05-04 22:45
Westlake signs LOI to buy Vynova Wilhelmshaven PVC, VCM site in Germany
Westlake signs LOI to buy Vynova Wilhelmshaven PVC, VCM site in Germany Westlake entered non-binding letter of intent on April 27, 2026 to acquire VYNOVA Wilhelmshaven PVC and VCM production site in Wilhelmshaven, Germany. Talks involve Westlake Vinnolit unit and VYNOVA Wilhelmshaven preliminary ins
05-01 21:58
GENOVA Director Akinao Ueda Resigns, Board Structure Maintained
GENOVA Inc. ( ($JP:9341) ) has issued an update. GENOVA Inc. announced that Boa...
04-30 16:29
NOV Q1 2026 Earnings Call Transcript
NOV (NYSE:NOV) held its first-quarter earnings conference call on Tuesday. Belo...
04-29 05:11
Quest Diagnostics Q1 2026 Earnings Call: Complete Transcript
Quest Diagnostics (NYSE:DGX) released first-quarter financial results and hoste...
04-21 21:33
BRIEF-GE Vernova Hitachi Nuclear Energy Signs Agreement With AFRY For BWRX-300 SMR Deployment
BRIEF-GE Vernova Hitachi Nuclear Energy Signs Agreement With AFRY For BWRX-300 SMR Deployment April 7 (Reuters) - GE Vernova Inc GEV.N : GE VERNOVA - GE VERNOVA HITACHI NUCLEAR ENERGY SIGNS AGREEMENT WITH AFRY FOR BWRX-300 SMR DEPLOYMENT GE VERNOVA - UNDER COLLABORATION AFRY TO PROVIDE ENGINEERING
04-07 15:45
Novamarine boosts 2025 revenue amid strategic shift and rising investments
The latest update is out from Novamarine S.P.A. ( ($IT:NOVA) ). Novamarine repo...
03-31 04:22
BRIEF-Novartis Agrees To Acquire Excellergy, Inc.
BRIEF-Novartis Agrees To Acquire Excellergy, Inc. March 27 (Reuters) - Novartis AG NOVN.S : NOVARTIS AGREES TO ACQUIRE EXCELLERGY, INC., BUILDING ON ALLERGY LEADERSHIP WITH NEXT-GENERATION ANTI-IGE INNOVATION NOVARTIS AG - TO PAY UP TO $2 BILLION TO BUY EXCELLERGY NOVARTIS AG - NOVARTIS WILL PAY UP
03-27 14:05
NovoCure Tumor Treating Fields Shows Improved Outcomes In Tough Pancreatic Cancer
NovoCure shares rise after PANOVA-4 data show higher disease control and survival signals in metastatic pancreatic cancer.
03-26 23:19
LB Pharmaceuticals Starts Its Pivotal Phase 3 Study Of LB-102 To Treat Schizophrenia
LB Pharmaceuticals Inc ("LB Pharmaceuticals" or the "Company") (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive major depressive disorder
03-25 20:01
